Covid-19 Impact on Cancer Diagnostics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Cancer Diagnostics, including the following market information:
Major competitors identified in this market include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare, C.R. Bard, etc.
Based on the Region:
- Global Cancer Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Cancer Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Cancer Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Cancer Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Siemens Healthcare, C.R. Bard, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Platform-based
- Instrument-based
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cancer Diagnostics Industry
1.7 COVID-19 Impact: Cancer Diagnostics Market Trends
2 GLOBAL CANCER DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Cancer Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cancer Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Cancer Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Cancer Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Cancer Diagnostics Market
3.4 Key Players Cancer Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON CANCER DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Platform-based
1.4.2 Instrument-based
4.2 By Type, Global Cancer Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON CANCER DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Breast Cancer
5.5.2 Lung Cancer
5.5.3 Colorectal Cancer
5.5.4 Melanoma
5.5.5 Others
5.2 By Application, Global Cancer Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Cancer Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Business Overview
7.1.2 Becton, Dickinson and Company Cancer Diagnostics Quarterly Revenue, 2020
7.1.3 Becton, Dickinson and Company Cancer Diagnostics Product Introduction
7.1.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Business Overview
7.2.2 GE Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.2.3 GE Healthcare Cancer Diagnostics Product Introduction
7.2.4 GE Healthcare Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Cancer Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Cancer Diagnostics Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Cancer Diagnostics Quarterly Revenue, 2020
7.4.3 Roche Cancer Diagnostics Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Cancer Diagnostics Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Cancer Diagnostics Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Business Overview
7.6.2 Agilent Technologies Cancer Diagnostics Quarterly Revenue, 2020
7.6.3 Agilent Technologies Cancer Diagnostics Product Introduction
7.6.4 Agilent Technologies Response to COVID-19 and Related Developments
7.7 Illumina
7.7.1 Illumina Business Overview
7.7.2 Illumina Cancer Diagnostics Quarterly Revenue, 2020
7.7.3 Illumina Cancer Diagnostics Product Introduction
7.7.4 Illumina Response to COVID-19 and Related Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Business Overview
7.8.2 Siemens Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.8.3 Siemens Healthcare Cancer Diagnostics Product Introduction
7.8.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.9 C.R. Bard
7.9.1 C.R. Bard Business Overview
7.9.2 C.R. Bard Cancer Diagnostics Quarterly Revenue, 2020
7.9.3 C.R. Bard Cancer Diagnostics Product Introduction
7.9.4 C.R. Bard Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cancer Diagnostics Industry
1.7 COVID-19 Impact: Cancer Diagnostics Market Trends
2 GLOBAL CANCER DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Cancer Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cancer Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Cancer Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Cancer Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Cancer Diagnostics Market
3.4 Key Players Cancer Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON CANCER DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Platform-based
1.4.2 Instrument-based
4.2 By Type, Global Cancer Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON CANCER DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Breast Cancer
5.5.2 Lung Cancer
5.5.3 Colorectal Cancer
5.5.4 Melanoma
5.5.5 Others
5.2 By Application, Global Cancer Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Cancer Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Business Overview
7.1.2 Becton, Dickinson and Company Cancer Diagnostics Quarterly Revenue, 2020
7.1.3 Becton, Dickinson and Company Cancer Diagnostics Product Introduction
7.1.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Business Overview
7.2.2 GE Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.2.3 GE Healthcare Cancer Diagnostics Product Introduction
7.2.4 GE Healthcare Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Cancer Diagnostics Quarterly Revenue, 2020
7.3.3 Abbott Cancer Diagnostics Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Cancer Diagnostics Quarterly Revenue, 2020
7.4.3 Roche Cancer Diagnostics Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Business Overview
7.5.2 Thermo Fisher Scientific Cancer Diagnostics Quarterly Revenue, 2020
7.5.3 Thermo Fisher Scientific Cancer Diagnostics Product Introduction
7.5.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Business Overview
7.6.2 Agilent Technologies Cancer Diagnostics Quarterly Revenue, 2020
7.6.3 Agilent Technologies Cancer Diagnostics Product Introduction
7.6.4 Agilent Technologies Response to COVID-19 and Related Developments
7.7 Illumina
7.7.1 Illumina Business Overview
7.7.2 Illumina Cancer Diagnostics Quarterly Revenue, 2020
7.7.3 Illumina Cancer Diagnostics Product Introduction
7.7.4 Illumina Response to COVID-19 and Related Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Business Overview
7.8.2 Siemens Healthcare Cancer Diagnostics Quarterly Revenue, 2020
7.8.3 Siemens Healthcare Cancer Diagnostics Product Introduction
7.8.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.9 C.R. Bard
7.9.1 C.R. Bard Business Overview
7.9.2 C.R. Bard Cancer Diagnostics Quarterly Revenue, 2020
7.9.3 C.R. Bard Cancer Diagnostics Product Introduction
7.9.4 C.R. Bard Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Cancer Diagnostics Assessment
Table 9. COVID-19 Impact: Cancer Diagnostics Market Trends
Table 10. COVID-19 Impact Global Cancer Diagnostics Market Size
Table 11. Global Cancer Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Cancer Diagnostics Market Growth Drivers
Table 14. Global Cancer Diagnostics Market Restraints
Table 15. Global Cancer Diagnostics Market Opportunities
Table 16. Global Cancer Diagnostics Market Challenges
Table 17. By Players, Cancer Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Cancer Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Cancer Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Cancer Diagnostics Market
Table 21. Key Players Cancer Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Cancer Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Cancer Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Cancer Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Becton, Dickinson and Company Business Overview
Table 58. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Becton, Dickinson and Company Cancer Diagnostics Product
Table 60. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 61. GE Healthcare Business Overview
Table 62. GE Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GE Healthcare Cancer Diagnostics Product
Table 64. GE Healthcare Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Cancer Diagnostics Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. Roche Business Overview
Table 70. Roche Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Roche Cancer Diagnostics Product
Table 72. Roche Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Cancer Diagnostics Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Agilent Technologies Cancer Diagnostics Product
Table 80. Agilent Technologies Response to COVID-19 and Related Developments
Table 81. Illumina Business Overview
Table 82. Illumina Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Illumina Cancer Diagnostics Product
Table 84. Illumina Response to COVID-19 and Related Developments
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Siemens Healthcare Cancer Diagnostics Product
Table 88. Siemens Healthcare Response to COVID-19 and Related Developments
Table 89. C.R. Bard Business Overview
Table 90. C.R. Bard Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. C.R. Bard Cancer Diagnostics Product
Table 92. C.R. Bard Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Cancer Diagnostics Assessment
Table 9. COVID-19 Impact: Cancer Diagnostics Market Trends
Table 10. COVID-19 Impact Global Cancer Diagnostics Market Size
Table 11. Global Cancer Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Cancer Diagnostics Market Growth Drivers
Table 14. Global Cancer Diagnostics Market Restraints
Table 15. Global Cancer Diagnostics Market Opportunities
Table 16. Global Cancer Diagnostics Market Challenges
Table 17. By Players, Cancer Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Cancer Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Cancer Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Cancer Diagnostics Market
Table 21. Key Players Cancer Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Cancer Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Cancer Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Cancer Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Cancer Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Becton, Dickinson and Company Business Overview
Table 58. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Becton, Dickinson and Company Cancer Diagnostics Product
Table 60. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 61. GE Healthcare Business Overview
Table 62. GE Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. GE Healthcare Cancer Diagnostics Product
Table 64. GE Healthcare Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Cancer Diagnostics Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. Roche Business Overview
Table 70. Roche Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Roche Cancer Diagnostics Product
Table 72. Roche Response to COVID-19 and Related Developments
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Thermo Fisher Scientific Cancer Diagnostics Product
Table 76. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Agilent Technologies Cancer Diagnostics Product
Table 80. Agilent Technologies Response to COVID-19 and Related Developments
Table 81. Illumina Business Overview
Table 82. Illumina Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Illumina Cancer Diagnostics Product
Table 84. Illumina Response to COVID-19 and Related Developments
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Siemens Healthcare Cancer Diagnostics Product
Table 88. Siemens Healthcare Response to COVID-19 and Related Developments
Table 89. C.R. Bard Business Overview
Table 90. C.R. Bard Cancer Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. C.R. Bard Cancer Diagnostics Product
Table 92. C.R. Bard Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Cancer Diagnostics Product Picture
Figure 2. Cancer Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Cancer Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Cancer Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Cancer Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Cancer Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Cancer Diagnostics Market Size Market Share, 2019-2021
Figure 1. Cancer Diagnostics Product Picture
Figure 2. Cancer Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Cancer Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Cancer Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Cancer Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Cancer Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Cancer Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Cancer Diagnostics Market Size Market Share, 2019-2021
